Cargando…

On Modelling Minimal Disease Activity

OBJECTIVE: To explore methods for statistical modelling of minimal disease activity (MDA) based on data from intermittent clinic visits. METHODS: The analysis was based on a 2‐state model. Comparisons were made between analyses based on “complete case” data from visits at which MDA status was known,...

Descripción completa

Detalles Bibliográficos
Autores principales: Jackson, Christopher H., Su, Li, Gladman, Dafna D., Farewell, Vernon T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4949508/
https://www.ncbi.nlm.nih.gov/pubmed/26315478
http://dx.doi.org/10.1002/acr.22687
_version_ 1782443441361256448
author Jackson, Christopher H.
Su, Li
Gladman, Dafna D.
Farewell, Vernon T.
author_facet Jackson, Christopher H.
Su, Li
Gladman, Dafna D.
Farewell, Vernon T.
author_sort Jackson, Christopher H.
collection PubMed
description OBJECTIVE: To explore methods for statistical modelling of minimal disease activity (MDA) based on data from intermittent clinic visits. METHODS: The analysis was based on a 2‐state model. Comparisons were made between analyses based on “complete case” data from visits at which MDA status was known, and the use of hidden model methodology that incorporated information from visits at which only some MDA defining criteria could be established. Analyses were based on an observational psoriatic arthritis cohort. RESULTS: With data from 856 patients and 7,024 clinic visits, analysis was based on virtually all visits, although only 62.6% provided enough information to determine MDA status. Estimated mean times for an episode of MDA varied from 4.18 years to 3.10 years, with smaller estimates derived from the hidden 2‐state model analysis. Over a 10‐year period, the estimated expected times spent in MDA episodes of longer than 1 year was 3.90 to 4.22, and the probability of having such an MDA episode was estimated to be 0.85 to 0.91, with longer times and greater probabilities seen with the hidden 2‐state model analysis. CONCLUSION: A 2‐state model provides a useful framework for the analysis of MDA. Use of data from visits at which MDA status can not be determined provide more precision, and notable differences are seen in estimated quantities related to MDA episodes based on complete case and hidden 2‐state model analyses. The possibility of bias, as well as loss of precision, should be recognized when complete case analyses are used.
format Online
Article
Text
id pubmed-4949508
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-49495082016-07-28 On Modelling Minimal Disease Activity Jackson, Christopher H. Su, Li Gladman, Dafna D. Farewell, Vernon T. Arthritis Care Res (Hoboken) Methodology OBJECTIVE: To explore methods for statistical modelling of minimal disease activity (MDA) based on data from intermittent clinic visits. METHODS: The analysis was based on a 2‐state model. Comparisons were made between analyses based on “complete case” data from visits at which MDA status was known, and the use of hidden model methodology that incorporated information from visits at which only some MDA defining criteria could be established. Analyses were based on an observational psoriatic arthritis cohort. RESULTS: With data from 856 patients and 7,024 clinic visits, analysis was based on virtually all visits, although only 62.6% provided enough information to determine MDA status. Estimated mean times for an episode of MDA varied from 4.18 years to 3.10 years, with smaller estimates derived from the hidden 2‐state model analysis. Over a 10‐year period, the estimated expected times spent in MDA episodes of longer than 1 year was 3.90 to 4.22, and the probability of having such an MDA episode was estimated to be 0.85 to 0.91, with longer times and greater probabilities seen with the hidden 2‐state model analysis. CONCLUSION: A 2‐state model provides a useful framework for the analysis of MDA. Use of data from visits at which MDA status can not be determined provide more precision, and notable differences are seen in estimated quantities related to MDA episodes based on complete case and hidden 2‐state model analyses. The possibility of bias, as well as loss of precision, should be recognized when complete case analyses are used. John Wiley and Sons Inc. 2016-02-23 2016-03 /pmc/articles/PMC4949508/ /pubmed/26315478 http://dx.doi.org/10.1002/acr.22687 Text en © 2016 The Authors. Arthritis Care & Research published by Wiley Periodicals, Inc. on behalf of the American College of Rheumatology. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Methodology
Jackson, Christopher H.
Su, Li
Gladman, Dafna D.
Farewell, Vernon T.
On Modelling Minimal Disease Activity
title On Modelling Minimal Disease Activity
title_full On Modelling Minimal Disease Activity
title_fullStr On Modelling Minimal Disease Activity
title_full_unstemmed On Modelling Minimal Disease Activity
title_short On Modelling Minimal Disease Activity
title_sort on modelling minimal disease activity
topic Methodology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4949508/
https://www.ncbi.nlm.nih.gov/pubmed/26315478
http://dx.doi.org/10.1002/acr.22687
work_keys_str_mv AT jacksonchristopherh onmodellingminimaldiseaseactivity
AT suli onmodellingminimaldiseaseactivity
AT gladmandafnad onmodellingminimaldiseaseactivity
AT farewellvernont onmodellingminimaldiseaseactivity